Mankind Pharma Sees Significant Open Interest Surge Amid Active Trading Environment

Mankind Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant increase in open interest today. The latest open interest stands at 10,845 contracts, reflecting a rise of 1,133 contracts or 11.67% from the previous open interest of 9,712. This uptick in open interest coincides with a trading volume of 15,648 contracts, indicating robust activity in the derivatives market.
In terms of price performance, Mankind Pharma has outperformed its sector by 2.64%, with a notable 3.72% gain over the past two days. The stock reached an intraday high of Rs 2,500, marking a 2.81% increase during the session. The weighted average price suggests that more volume was traded closer to the lower end of the price range, while the stock remains above its 5-day, 20-day, 50-day, and 100-day moving averages, although it is below the 200-day moving average.

Despite a decline in delivery volume, which fell by 72.57% compared to the 5-day average, Mankind Pharma maintains a market capitalization of Rs 1,03,863.19 crore, positioning it firmly within the large-cap category. Overall, the increase in open interest and recent price performance highlights the stock's active trading environment.